EUVIMEDEUVIMED entdecken
Crossref

Physician Compliance with Multidisciplinary Tumor Board Recommendations for Managing Gynecological Cancers

Clara Naessens, Jerome Laloze, Sophie Leobon, Tristan Gauthier, Aymeline Lacorre, Jacques Monteil, Laurence Venat, Elise Deluche iD

Future Oncology · 2023

DOI: 10.2217/fon-2022-1183 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Future Oncology, 2023. Verfasst von Clara Naessens und 7 weiteren Autor:innen. Beteiligte Einrichtung: Radiation Therapy Department, Limoges University Hospital, Limoges, 87000, France. Hauptthemen laut MEDLINE: Genital Neoplasms, Female, Guideline Adherence. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Evaluation of compliance with gynecological multidisciplinary tumor board (MTB) recommendations and its impact. Patients & methods: All patient records discussed in our MTB from 2018 to 2020 were analyzed.

Results

We analyzed 437 MTB recommendations concerning 166 patients. Each patient was discussed an average of 2.6 (1.0-4.2) times. Of the 789 decisions, the decision was not followed 102 times (12.9%), corresponding to 85 MTB meetings (19.5%). Of these, 72 recommendations concerned therapeutic changes (70.5%), and 30 concerned non-therapeutic changes (29.5%). Of these 85 MTB decisions, 60 (71%) led to a new MTB submission. Noncompliance with MTB decisions decreased the overall survival (46 vs 138 months; p = 0.003).

Conclusion

Improving compliance with MTB decisions is crucial to enhance patient outcomes. In multidisciplinary tumor board (MTB) meetings, a team of experts discuss the diagnosis and management of cancer patients. While MTB treatment decisions and the reasoning behind them are well documented, the application of these decisions in practice and the associated impact on survival are unknown. This study evaluated compliance with recommendations made during gynecological weekly MTB meetings and the resulting impact on patient management. Between 2018 and 2020, 166 patients were discussed in 437 MTB meetings (each patient was discussed an average of 2.6 times during this period). Noncompliance with the MTB recommendations affected 85/437 MTB meetings (19.5%). Of these, 57 recommendations were therapeutic changes (67.1%) and 28 were non-therapeutic changes (32.9%). In 60 cases (71%), noncompliance with the MTB led to resubmission of the patient data to the MTB. Noncompliance with the board recommendations led to a decrease in patient survival (46 vs 138 months; p = 0.003). This study is expected to raise awareness among practitioners. Considered an essential part of the delivery of high-quality cancer treatment, the implementation of MTB decisions requires further verification.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genital Neoplasms, FemaleGuideline AdherenceHumansFemaleOutcome Assessment, Health CareRetrospective StudiesAdultMiddle AgedAgedAged, 80 and over

Stichwörter der Autor:innen

compliancegynecological cancersmultidisciplinary tumor boards

Autor:innen und Institutionen

  • Radiation Therapy Department, Limoges University Hospital, Limoges, 87000, France.
  • Reconstructive Surgery Department, Limoges University Hospital, Limoges, 87000, France.
  • Medical Oncology Department, Limoges University Hospital, Limoges, 87000, France.
  • Gynecological Department, Limoges University Hospital, Limoges, 87000, France.
  • Nuclear Medicine Department, Limoges University Hospital, Limoges, 87000, France.

ORCID-Profile: Elise Deluche

Zitieren

APA

Naessens, C., Laloze, J., Leobon, S., Gauthier, T., Lacorre, A., Monteil, J., Venat, L., & Deluche, E. (2023). Physician Compliance with Multidisciplinary Tumor Board Recommendations for Managing Gynecological Cancers. Future Oncology. https://doi.org/10.2217/fon-2022-1183

Vancouver

Naessens C, Laloze J, Leobon S, Gauthier T, Lacorre A, Monteil J, et al. Physician Compliance with Multidisciplinary Tumor Board Recommendations for Managing Gynecological Cancers. Future Oncology. 2023. doi:10.2217/fon-2022-1183

BibTeX
@article{Naessens2023,
  author = {Naessens, Clara and Laloze, Jerome and Leobon, Sophie and Gauthier, Tristan and Lacorre, Aymeline and Monteil, Jacques and Venat, Laurence and Deluche, Elise},
  title = {Physician Compliance with Multidisciplinary Tumor Board Recommendations for Managing Gynecological Cancers},
  journal = {Future Oncology},
  year = {2023},
  doi = {10.2217/fon-2022-1183}
}
Kostenlos starten →